BioMed Research International

Gliomas


Status
Published

1Medical Oncology 1, Venetian Institute of Oncology – IRCCS, Padua, Italy

2Department of Neuro-Oncology, University Hospital, Torino, Italy

3Department of Neurosurgery, Azienda Ospedaliera-Padua University, Padua, Italy

4Neurology Unit at National Cancer Institute Regina Elena, Rome, Italy

5Department of Neuro-Oncology, Hopitaux de Marseille, Marseille, France

6Department of Neuro-Oncology, Université P8M Curie, GH Pitié-Salpêtrière, Paris


Gliomas

Description

Gliomas are a heterogeneous group of tumors developing from glial cells in the central nervous system. They include high-grade gliomas (such as glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, and anaplastic oligodendroglioma) and low-grade gliomas (such as pilocytic astrocytoma, grade II oligodendroglioma/astrocytoma/ependymoma, and diffuse astrocytoma).

In the last years, there have been important developments about their diagnosis, their biological mechanism, genetic mutations, and moreover, there have been numerous clinical trials regarding their treatment.

New technological instruments such as magnetic resonance imaging with spectroscopy and perfusion and positron emission tomography with methionine can help in the correct diagnosis for these tumors.

The recent discovery of IDH gene mutation in gliomas has been an important contribution to the knowledge of biological mechanism and prognosis of these tumors.

Antiangiogenic treatments for glioblastoma patients have been tested in numerous clinical trials, in particular, the role of bevacizumab as first or second line therapy.

We invite authors to submit original research and review articles that will stimulate the continuing efforts to understand the molecular pathology underlying gliomas, the development of new technological instruments for better diagnosis, and the development of new treatments and new knowledge about psychological approaches and supportive care for these patients and their caregivers. Potential topics include, but are not limited to:

  • Development of novel treatments, such as antiangiogenic drugs or vaccines, for gliomas
  • Advances in molecular mechanisms of gliomas
  • Developments of novel techniques in neurosurgery
  • Developments of molecular pathology in gliomas
  • Development of new prognostic and predictive factors in gliomas
  • Developments of new tools for diagnosis of gliomas
  • Recent advances in genetic mutations in gliomas
  • Advances in cancer stem cells in gliomas
  • Palliative care in neurooncology for patients with gliomas
  • Quality of life and neurocognitive functions in patients with gliomas

Before submission authors should carefully read over the journal's Author Guidelines which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/neuroscience/gli/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 470523
  • - Editorial

Gliomas

Giuseppe Lombardi | Alessandro Della Puppa | ... | Vittorina Zagonel
  • Special Issue
  • - Volume 2014
  • - Article ID 647356
  • - Clinical Study

Diffusion Tensor Histogram Analysis of Pediatric Diffuse Intrinsic Pontine Glioma

Emilie A. Steffen-Smith | Joelle E. Sarlls | ... | Katherine E. Warren
  • Special Issue
  • - Volume 2014
  • - Article ID 657953
  • - Clinical Study

Salvage Radiosurgery for Selected Patients with Recurrent Malignant Gliomas

Miguel Martínez-Carrillo | Isabel Tovar-Martín | ... | José Expósito-Hernández
  • Special Issue
  • - Volume 2014
  • - Article ID 198697
  • - Research Article

IDH1R132H Mutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia

Xiao-Wei Wang | Marianne Labussière | ... | Marc Sanson
  • Special Issue
  • - Volume 2014
  • - Article ID 351252
  • - Clinical Study

Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas

V. Vaccaro | A. Fabi | ... | A. Pace
  • Special Issue
  • - Volume 2014
  • - Article ID 540236
  • - Research Article

IDH Mutations: Genotype-Phenotype Correlation and Prognostic Impact

Xiao-Wei Wang | Pietro Ciccarino | ... | Marianne Labussière
  • Special Issue
  • - Volume 2014
  • - Article ID 549742
  • - Review Article

BMPs as Therapeutic Targets and Biomarkers in Astrocytic Glioma

Pilar González-Gómez | Nilson Praia Anselmo | Helena Mira
  • Special Issue
  • - Volume 2014
  • - Article ID 827327
  • - Research Article

Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature

Soufiane El Hallani | Carole Colin | ... | Marc Sanson
  • Special Issue
  • - Volume 2014
  • - Article ID 232561
  • - Clinical Study

5-Aminolevulinic Acid Fluorescence in High Grade Glioma Surgery: Surgical Outcome, Intraoperative Findings, and Fluorescence Patterns

Alessandro Della Puppa | Pietro Ciccarino | ... | Marta Rossetto
  • Special Issue
  • - Volume 2014
  • - Article ID 154350
  • - Clinical Study

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area

Anna Luisa Di Stefano | Niels Bergsland | ... | Stefano Bastianello
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.